Dr. Baoqing Li, MD

Dr. Li practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Dr. Li's NPI, 1316026511, was assigned on November 6, 2006. Dr. Li graduated from New York Medical College in 2005. Dr. Li's New York license number on file is 257087.

Dr. Li's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Dr. Li's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Li to 2 more medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Li is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Li's licenses on file in 5 states: New York, California, Connecticut, Kansas and Nebraska.

Dmand AI lists bone cancer radiation, brain cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Li treats.

CMS data shows 759 Medicare services from Dr. Li across 10 procedure codes in 2024, for 82 Medicare patients. Medicare paid $69,032 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 72, with 38% women.

In 2024, Dr. Li wrote 25 Medicare Part D claims for 23 patients. 88% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $179 in total drug cost. In 2021, CMS named 16 claims across 1 drug.

Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Li, published from 2001 to 2014. 2010 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Blotting, Western and Carcinoma, Squamous Cell. Dr. Li's most frequent co-authors are Allen M. Chen, MD, Kathryn Cecilia Arbour, MD and Donald Gregory Farwell, MD.

CMS Open Payments shows 24 general payments to Dr. Li from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 51% of the total. Novocure Inc. paid the most, $3,118.

Dmand AI lists 3 awards for Dr. Li, most recently ASCO Cancer Foundation Merit Award in 2010.

Dr. Li graduated from New York Medical College in 2005.

Dr. Li is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.